News
Vinay Prasad is back at the FDA after last month's surprise ouster. Will he stay this time?
Vinay Prasad, M.D., has rejoined the FDA, the latest turn in a monthslong stretch of leadership turnover at the agency. | “At the FDA’s request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,
He's Back: Vinay Prasad Returns As FDA CBER Head
Vinay Prasad, MD, MPH, who was appointed to run the FDA's Center for Biologics Evaluation and Research (CBER) in May, then resigned in late July after he was criticized by right-wing influencer Laura Loomer, is now back running CBER, according to multiple media reports.
Vinay K. Prasad, MD, MPH, a controversial hematologist-oncologist who abruptly left his two leadership roles at FDA last ...
The new FDA vaccine chief, Dr. Vinay Prasad was an outspoken critic of the agency's response to the pandemic, including the former vaccine chief, Dr. Peter Marks.
Dr. Vinay Prasad, an oncologist who previously criticized the FDA and was a fierce critic of COVID-19 vaccine and mask mandates, was appointed in May.
Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter Marks.
A controversial hematologist-oncologist who joined FDA this spring and quickly became its top regulator has left the ...
Oncologist Vinay Prasad was named the new vaccine chief by the FDA in May 2025. Here’s what you need to know.
Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter Marks.
Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter Marks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback